Mucosal immunity to influenza without IgA: An IgA knockout mouse model

Journal of Immunology

Volumn 162, Issue 5, 1999, Pages 2530-2537

  Mbawuike, Innocent N ^a,b   Pacheco, Susan ^b   Acuna, Catherine L ^a   Switzer, Kirsten C ^a   Zhang, Yongxin ^a   Harriman, Gregory R ^b,c  

^a Respiratory Pathogens Research Unit   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Immunology Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

ANIMAL MODEL; ARTICLE; GENE TARGETING; INFECTION CONTROL; INFLUENZA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA;

ADOPTIVE TRANSFER; ANIMALS; CHOLERA TOXIN; FEMALE; IGA DEFICIENCY; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; INFLUENZA VACCINES; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 0033104697     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Conley, M. E., and D. L. Delacroix. 1987. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense. Ann. Intern. Med. 106:892.
2. Brandtzaeg, P. 1989. Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 146:13.
3. Czinn, S. J., A. Cai, and J. G. Nedrud. 1993. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11:637.
4. French, M. A., K. A. Denis, R. Dawkins, and J. B. Peter. 1995. Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4. Clin. Exp. Immunol. 100:47.
5. Czinn, S. J., A. Cai, and J. G. Nedrud. 1993. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11:637.
6. Winner, L. D., J. Mack, R. Weltzin, J. J. Mekalanos, J. P. Kraehenbuhl, and M. R. Neutra. 1991. New mode for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vitro cholerae infection. Infect. Immun. 59:977.
7. Renegar, K. B., and P. A. Small. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972.
8. Renegar, K. B., and P. A. Small. 1991. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65:2146.
9. Persson, E., P. Eneroth, and S. Jeansson. 1988. Secretory IgA against herpes simplex virus in cervical secretions. Genitourin. Med. 64:373.
10. Mazanec, M. B., J. G. Nedrud, and M. E. Lamm. 1987. Immunoglobulin A monoclonal antibodies protect against Sendai virus. J. Virol. 61:2624.
11. Mazanec, M. B., C. L. Coudret, and D. R. Fletcher. 1995. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69:1339.
12. Mazanec, M. B., C. S. Kaetzel, M. E. Lamm, D. Fletcher, J. Peterra, and J. G. Nedrud. 1995. Intracellular neutralization of Sendai and influenza viruses by IgA monoclonal antibodies. Adv. Exp. Med. Biol. 371A:651.
13. Tomoda, T., H. Morita, T. Kurashige, and H. F. Maassab. 1995. Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response. Vaccine 13:185.
14. Burns, J. W., M. Siadat-Pajouh, A.-A. Krishnaney, and H. B. Greenberg. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104.
15. 2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect. Immun. 40:1044.
16. Offit, P. A., and H. F. Clark. 1985. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J. Virol. 54:58.
17. Brandtzaeg, P. 1995. Molecular and cellular aspects of the secretory immunoglobulin system. APMIS 103:1.
18. Kilian, M., J. Mestecky, and M. W. Russell. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A (IgA) and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52:296.
19. Russell-Jones, G. J., P. L. Ey, and B. L. Reynolds. 1981. Inhibition of cutaneous anaphylaxis and Arthus reactions in the mouse by antigen-specific IgA. Int. Arch. Allergy Appl. Immunol. 66:316.
20. Williams, R. C., and R. J. Gibbons. 1972. Inhibition of bacterial adherence by secretary immunoglobulin A: a mechanism of antigen disposal. Science 177:697.
21. Lamm, M. E., M. B. Mazaneca, J. G. Nedrud, and C. S. Kaetzel. 1995. New functions for mucosal IgA. Adv. Exp. Med. Biol. 371A:647.
22. Burrows P. D., and M. D. Cooper. 1997. IgA deficiency. Adv. Immunol. 65:245.
23. Hanson, L. A., J. Bjorkander, B. Carlsson, D. Roberton, and T. Soderstrom. 1988. The heterogeneity of IgA deficiency. J. Clin. Immunol. 8:159.
24. Fernandes F. R., A. T. Nagao, M. P. Mayer, F. Zelante, and M. M. Carneiro-Sampaio. 1995. Compensatory levels of salivary IgM anti-Streptococcus mutans antibodies in IgA-deficient patients. J. Invest. Allergol. Clin. Immunol. 5:151.
25. Norhagen, G. E., P.-E. Engstrom, L. Hammarstrom, P.-O. Soder, and C. I. F. Smith. 1989. Immunoglobulin levels in saliva in individuals with selective IgA deficiency: compensatory IgM secretion and its correlation with HLA and susceptibility to infections. J. Clin. Immunol. 9:279.
26. Preud'homme, J. L., and L. A. Hanson. 1990. IgG subclass deficiency. Immunodefic. Rev. 2:120.
27. McDermott, M. R., and J. Bienenstock. 1979. Evidence for a common mucosal system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. J. Immunol. 122:1892.
28. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75.
29. Hirabayashi, Y., H. Kurato, H. Funato, T. Nagamine, C. Aizawa, S. Tamura, K. Simada, and T. Kurata. 1990. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 8:243.
30. Nilssen, D. E., V. Friman, K. Theman, J. Bjorkander, A. Kilander, J. Holmgren, L. A. Hanson, and P. Brandtzaeg. 1993. B-cell activation in duodenal mucosa after oral cholera vaccination in IgA deficient subjects with or without IgG subclass deficiency. Scand. J. Immunol. 38:201.
31. Czerkinsky, C., M. W. Russell, N. Lycke, M. Lindblad, and J. Holmgren. 1989. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57:1072.
32. Butcher, E. C., R. V. Rouse, R. L. Coffman, C. N. Nottenburg, R. R. Hardy, and I. L. Weissman. 1982. Surface phenotype of Peyer's patch germinal center cells: implications for the role of germinal centers in B cell differentiation. J. Immunol. 129:2698.
33. Nedrud, J. G., X. Liang, N. Hague, and M. E. Lamm. 1987. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 139:3484.
34. Chen, K. S., and W. Strober. 1990. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response. Eur. J. Immunol. 20:433.
35. Tamura, S., H. Funato, T. Nagamine, C. Aizawa, and T. Kurata. 1989. Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. Vaccine 7:503.
36. Tamura, S., H. Asanuma, T. Tomita, K. Komase, K. Kawahara, H. Danbara, N. Hattori, K. Watanabe, Y. Suzuki, T. Nagamine, et al. 1994. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 12:1083.
37. Katz, J. M., X. Lu, S. A. Young, and J. C. Galphin. 1997. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J. Infect. Dis. 175:352.
38. Clements, M. L., R. F. Betts, E. L. Tierney, and B. R. Murphy. 1986. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine. J. Clin. Microbiol. 23:73.
39. Wright, P. F., B. R. Murphy, M. Kervina, E. M. Lawrence, M. A. Phelan, and D. T. Karzon. 1983. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect. Immun. 40:1092.
40. Tamura, S., H. Funato, Y. Hirabayashi, K. Kikuta, Y. Suzuki, T. Nagamine, C. Aizawa, M. Nakagawa, and T. Kurata. 1990. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine 8:479.
41. Liew, F. Y., S. M. Russell, G. Appleyard, C. M. Brand, and J. Beale. 1984. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14:350.
42. Palladino, G., K. Mozdzanowska, G. Washko, and W. Gerhard. 1995. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol 69:2075.
43. Harriman, G. R., M. Bogue, P. Rogers, M. Finegold, S. Pacheco, A. Bradley, Y. Zhang, and I. N. Mbawuike. 1999. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other immunoglobulin isotypes. J. Immunol. 162:2521.
44. McMahon, A. P., and A. Bradley. 1990. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62:1073.
45. Harriman, G. R., A. Bradley, S. Das, P. Rogers-Fani, and A. C. Davis. 1996. IgA class switch in 1 α exon-deficient mice: role of germline transcription in class switch recombination. J. Clin. Invest. 97:477.
46. Hasty, P., P. J. Rivera, C. Chang, and A. Bradley. 1991. Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol. Cell. Biol. 11:4509.
47. Harriman, G. R., D. Y. Kunimoto, J. F. Elliott, V. Paetkau, and W. Strober. 1988. The role of IL-5 in IgA B cell differentiation. J. Immunol. 140:3033.
48. + lamina propria T-cell lines: phenotypic and functional characterization. Immunology 75:66.
49. Tamura, S., A. Yamanaka, M. Shimohara, T. Tomita, K. Komase, Y. Tsuda, Y. Suzuki T. Nagamine, K. Kawahara, H. Danbara, et al. 1994. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 12:419.
50. Tamura, S., K. Ishihara, K. Miyata, C. Aizawa, and T. Kurata. 1995. Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin. Vaccine 13:339.
51. + cytotoxic T cells by immunization with killed influenza virus vaccine and effect of cholera toxin B subunit. Vaccine 11:1205.
52. Mbawuike, I. N., H. R. Six, T. R. Cate, and R. B. Couch. 1990. Maternal vaccination during pregnancy with inactivated influenza A virus protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes. J. Virol. 64:1370.
53. Mbawuike, I. N., S. B. Dillon, T. R. Cate, and R. B. Couch. 1994. Influenza A subtype cross-protection after immunization of outbred mice with purified chimeric NS1/HA2 influenza virus protein. Vaccine 12:1340.
54. Lycke, N. 1986. A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells. Scand. J. Immunol. 24:393.
55. Mbawuike, I. N., C. Acuna, D. Caballero, K. Pham-Nguyen, B. Gilbert, P. Petribon, and M. Harmon. 1996. Reversal of age-related deficient influenza virus-specific CTL responses and IFN-γ production by monophosphoryl lipid A. Cell. Immunol. 173:64.
56. 2-microglobulin-deficient, and J chain-deficient mice. J. Immunol. 158:1222.
57. Bogstedt, A. K., S. Nava, T. Wadstrom, and L. Hammarstrom. 1996. Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Clin. Exp. Immunol. 105:202.
58. Keitel, W. A., R. B. Couch, T. R. Cate, K. R. Hess, B. Baxter, J. M. Quarles, R. L. Atmar, and H. R. Six. 1994. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J. Clin. Microbiol. 32:2468.